Genmab A/SGMABNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+18.7%
5Y CAGR+29.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+18.7%/yr
vs +49.6%/yr prior
5Y CAGR
+29.4%/yr
Recent deceleration
Acceleration
-30.9pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
3.6x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $13.78B | -0.4% |
| 2024 | $13.84B | +26.6% |
| 2023 | $10.93B | +32.6% |
| 2022 | $8.24B | +50.8% |
| 2021 | $5.46B | +43.9% |
| 2020 | $3.80B | +39.2% |
| 2019 | $2.73B | +65.9% |
| 2018 | $1.64B | +61.1% |
| 2017 | $1.02B | +33.8% |
| 2016 | $763.29M | - |